chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No Appetite; was in bed for three days; Fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No Appetite), BEDRIDDEN (was in bed for three days), PYREXIA (Fever) and CHILLS (chills) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 021M020A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot. Past adverse reactions to the above products included Adverse event with Flu shot. Concurrent medical conditions included Heart disorder (Heart condition) since 1997. Concomitant products included ATORVASTATIN from 1997 to an unknown date for Heart disorder, LOSARTAN, CARVEDILOL, VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (D) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 18-Feb-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (No Appetite), BEDRIDDEN (was in bed for three days), PYREXIA (Fever) and CHILLS (chills). At the time of the report, DECREASED APPETITE (No Appetite), BEDRIDDEN (was in bed for three days), PYREXIA (Fever) and CHILLS (chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Patient did not experience any adverse events for dose 1 of Moderna COVID-19 vaccine.   This case was linked to MOD-2021-403386 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-Jan-2022: Follow yp received: Added secondary reporter.
Her arm (deltoid area) was swollen and red. Achy all over. She was given Vioxx 25mg and Medrol DP 4mg.
temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it; This spontaneous case was reported by an other health care professional and describes the occurrence of URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it). At the time of the report, URINARY INCONTINENCE (temporaraly lost control over my bladder/peed my pants with out even knowing it or feelining it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported.
arm sore as normal following vaccine for 3 days then pain became severe in muscle of upper right arm; pain mild when arm in neutral position and/or at rest but sever stabbing pain when arm is extended outward, upward or reaching backward; pain is sharp stabbing pain, very severe for less than a minute, slowly subsides; also very sore if I lie or lean on that arm; has been ongoing now for over 4 weeks without any relief or change
sore shoulder; Left side of her throat felt funny/sore; Tired; Slight problem swallowing; Felt a little dizzy; Felt like the left side of her face was swelling but she couldn't see swelling/felt weird; Heart was racing, was between 109-115 bpm; Lymph nodes on the left side of her neck started swelling; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (Slight problem swallowing), OROPHARYNGEAL PAIN (Left side of her throat felt funny/sore), DIZZINESS (Felt a little dizzy), SWELLING FACE (Felt like the left side of her face was swelling but she couldn't see swelling/felt weird) and HEART RATE INCREASED (Heart was racing, was between 109-115 bpm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer and Lymph node excision. Concurrent medical conditions included Allergy to antibiotic (Allergy to food and antibiotics.).    On 04-Feb-2021 at 3:22 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced DYSPHAGIA (Slight problem swallowing), DIZZINESS (Felt a little dizzy), SWELLING FACE (Felt like the left side of her face was swelling but she couldn't see swelling/felt weird), HEART RATE INCREASED (Heart was racing, was between 109-115 bpm) and LYMPHADENOPATHY (Lymph nodes on the left side of her neck started swelling). On 04-Feb-2021 at 5:00 PM, the patient experienced FATIGUE (Tired). On 05-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Left side of her throat felt funny/sore). On 06-Feb-2021, the patient experienced ARTHRALGIA (sore shoulder). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 04-Feb-2021, DYSPHAGIA (Slight problem swallowing) had resolved. On 05-Feb-2021, SWELLING FACE (Felt like the left side of her face was swelling but she couldn't see swelling/felt weird) and HEART RATE INCREASED (Heart was racing, was between 109-115 bpm) had resolved. On 06-Feb-2021, ARTHRALGIA (sore shoulder) had resolved. On 07-Feb-2021, LYMPHADENOPATHY (Lymph nodes on the left side of her neck started swelling) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Left side of her throat felt funny/sore), DIZZINESS (Felt a little dizzy) and FATIGUE (Tired) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Heart rate: 109-115 (High) 109-115 bpm. On 05-Feb-2021, Heart rate: 67 (Inconclusive) 67 bpm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Experienced an allergic reaction to PREVNAR-13; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 02206758 (Merck).  A female patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Experienced an allergic reaction to PREVNAR-13". Follow-up attempts are completed. No further information is expected.
Information has been received from a physician concerning a 14 year old female who on an unspecified date was intramuscular vaccinated with GARDASIL. Subsequently the patient immediately after fainted. The office called an ambulance. The patient had sought medical attention. Follow up information has been received from an office administrator. He reported that a couple of months ago a girl who got "several vaccines" (not specifically GARDASIL) got dizzy after the shots. An office employee called the ambulance by mistake. The girl was not transported any where, and she didn't faint. Additional information is not expected.
2nd dose admnistered on 07-May-2021 and booster administered on 01-Sep-2021; Felt like it set back runs high fever get chills; Felt like it set back runs high fever get chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Felt like it set back runs high fever get chills), CHILLS (Felt like it set back runs high fever get chills) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose admnistered on 07-May-2021 and booster administered on 01-Sep-2021) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Panuveitis.    No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) CF, prefilled pen. In 2021, the patient experienced PYREXIA (Felt like it set back runs high fever get chills) and CHILLS (Felt like it set back runs high fever get chills). On 01-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose admnistered on 07-May-2021 and booster administered on 01-Sep-2021). In 2021, PYREXIA (Felt like it set back runs high fever get chills) and CHILLS (Felt like it set back runs high fever get chills) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose admnistered on 07-May-2021 and booster administered on 01-Sep-2021) outcome was unknown.            Concomitant medication information was not provided by the reporter.  The patient received 3rd, booster on 01-Sep-2021.  The reporter's causality for the events with Humira (Adalimumab) was no reasonable possibility.  It was unknown if the patient was enrolled in a COVID-19 vaccine trial.  Treatment information was not provided by the reporter.
On 3/12/2021 pt states that her jaw was sore on the right side of her mouth when she was talking or chewing. On  3/14/2021 pt states her right side of her face felt swollen and tingly.  She said her right ear felt swollen.   She states the feeling was like she had been lidocaine on the right side of her face.  Pt was going to go to the ER  w/ these symptoms but subsided after 24 hours.  She no longer has any symptoms.
second dose past 36 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose past 36 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose past 36 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose past 36 days) had resolved.            No Concomitant use was reported.  Reporter stated she had no adverse events after initial dose of vaccine.  No treatment were reported.
dizziness; very ill feeling; sharp headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke (Experienced double stroke).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches). At the time of the report, DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Pt reports that 3-4 hours after receiving first Gardasil vaccine, she broke out in widespread hives.  She saw her PCP and was told possible reaction to Gardasil and was advised to discontinue the series.
SMALL AMOUNT OF MIST NOTICED WHEN VACCINE WAS INSERTED. Not evaluated by me.
I received my second dose of Pfizer vaccine about a week after I would have conceived my baby, due February 2nd 2022.  I started experiencing intense cramping in late July and was diagnosed Aug 3 2021 as having had a missed miscarriage at approx 10 weeks gestation.  I underwent a D&C procedure. I then conceived again late September and was diagnosed with a pregnancy of unknown location though there was a visible gestational sac. I was dosed with methotrexate to halt development and cause miscarriage and the growth did not respond to the methotrexate whatsoever so I was given a second D&C.
Patient developed redness, swelling, warmth, and tenderness to right upper arm, approximately measuring 3" x 5", treated with KEFLEX for ? cellulitis.
GAVE MODERNA VACCINE ON 3/31/2021 TO A 16YRS OLD PT DIDN'T HAVE ANY COMPLICATIONS OR SYMPTOMS. THE HEALTH CLINIC HAD TOLD US TO GIVE MODERNA VACCINE TO SOMEONE YOUNGER THEN 18YRS OLD.
Per guidance we are to discontinue monovalent mRNA boosters> All such boosters administered to 12+ year-old patients, after 31 AUG 2022, will need to be reported in VAERS as administration errors.
possible cellulitis of posterior upper arm w/10x6cm area of induration, redness & hot to touch;became progressive worse & was treated w/ATB & started to resolve;
He got his vaccine (4).  He had a very sore arm, and then the whole body got sore.  It was around 9:00 PM, could not really function.  He also had a headache, more in the upper thighs, could not function for about a day and a half.  Also had soreness in the upper arms.  He also had a kind of foggy brain, felt like he had the flu.  He took Bayer back and body for the symptoms, and an Advil.  He did not notify the doctor.    He did have some reaction to the last vaccine, but not as long as  period of time.  He states that he will never to another one as he felt so bad for so long.
Patient became pale with red speckles on his all around his face.  The periorbital area became dark purple.  He complained of mild shortness of breath within minutes of vaccine.  Oral allergy medication/Claritin was immediately given.  IM Benadryl on hand but care provider chose to wait and see how patient responded before upsetting him with another injection.  After 20 minutes, color had returned to normal and ease of breathing had returned. Breathing never became any more labored.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced suspected vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the suspected vaccination failure and shingles were unknown.   It was unknown if the reporter considered the suspected vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  The patient self-reported this case.                                        The age at vaccination was not reported. The patient received the shingles vaccine and had a case of shingles which was worst the doctor had seen. The patient did not have faith in vaccine. This case was considered as suspected vaccination failure since the details regarding completion of primary immunization schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
One year ago, I had been tested for Rheumatoid Arthritis but tested negative. After second shot, I was hurting bad. Got retested. Had rheumatoid arthritis.
Swelling and induration about 20 cm X 23 cm, pain, itching, warmth,  developed around 24 hours, pain worsening over next 24 hours, swelling improved slighty over second 24 hours.
Left arm rash within minutes of receiving vaccine.  Then resolved. Headache, dizziness, difficulty concentrating, difficulty focusing vision, right ear pain-intermittent. Shortness of breath-improved with albuterol inhaler. History of asthma.
Accelerated heart beat. Numbness in left foot. Severe headaches,  fever, night sweats, problems with menstrual cycle, cramps, blood clot in menstruation. Headaches lasting 5 consecutive days. Increased seasonal allergies.
I started experiencing very heavy vaginal bleeding and bruising on left side of my body. I had a consultation via telemedicine and was sent to urgent care and them referred to a hematologist. I have always had issues with excessive bleeding but has been aggravated by the vaccine. I was diagnosed with PAI 1 deficiency and blood coagulation was disrupted by the vaccine. I was prescribed Tranexamic acid by the Hematologist.
Vomiting, intussusception  10/14/08 Reviewed hospital medical records of 9/25-26/2008. FINAL DX: intussusception, enema reduced Records reveal patient experienced bilious vomiting, lethargy, irritability & abdominal pain.  IS reduced in radiology & admitted overnight for observation.  Progressed well & d/c to home.
Insomnia starting a few days after first shot. Heart rate 71 and blood pressure 130/87 at time of insomnia.
mom stated that 1hr p/vax fever 102 & pt was limp & other sx noted;immed took pt to ER where they drew lab work everything turned up negative;next day mom took pt to MD & he stated must have been rxn to shots nothing else was done
Adacel administered on 11/28/05 right arm. Mother called today with report of 25 cent piece sized, red, warm, very little discomfort. (12/1/05) Menactra given in left arm no symptoms.
Breakthrough COVID-19 case: I started to have a sore throat, stuff nose and my ears hurt. When I woke up the next morning my voice was almost gone and I was extremely fatigued and completely congested. I decided to take a rapid test and that came back positive. I emailed my doctor. She called in a prescription of Molnupiravir 200mg (4) twice a day for 5 days. I am not as congested now and its mainly just in my head.
This spontaneous case, initially received on 07-Sep-2018, reported by a pharmacist and concerns a 64-year-old, adult, female patient. The patient's medical history and concomitant medications were unknown. On an unspecified date in 2017, the patient was administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: unknown, expiry date: not reported). After vaccination, within 24 hours, the patient experienced allergic reaction and developed swelling all over. It was reported that, the patient had a visit to primary care physician. At the time of this report, the patient had recovered from the events (swelling and allergic reaction). The reporter assessed the case as non-serious.
This case was reported by a nurse and described the occurrence of elevated liver enzymes in a 44 year old female subject who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. The subject's medical history was notable for obesity, bariatric surgery in October 2004, and a weight loss of 70 pounds. Concurrent medications included Vitamins for nutritional supplementation. On 7/26/05 the subject received the second dose of Engerix B. On 8/4/05, 9 days after vaccination with Engerix B, the subject experienced elevated liver enzymes. At the time of initial reporting, the elevated liver enzymes were unresolved. The nurse considered the elevated liver enzymes to possibly be related to vaccination with Engerix. B. Comment: Elevated liver enzymes was assessed as medically serious (OMIC).
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid from 02Dec2022 to 07Dec2022.  Clinical course: Reported as, symptoms improved but began again one day after ending treatment with paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
last week on Sunday I ended up with vertigo I was doing some pluming work and after I got up from  doing my works its when it hit me.  I saw the doctor. on Monday they diagnosed me with vertigo without nystagmus. it stayed for about 4 days.  They recommended that I do some specialized exercise for the issue and this helped me.
Dose administered after 30-day Use By Date/Vial was initially stored in the refrigerator on 19-AUG-2022 and vaccine was administered on 21-SEP-2022; No adverse event; receiving a dose after its beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving a dose after its beyond use date), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date/Vial was initially stored in the refrigerator on 19-AUG-2022 and vaccine was administered on 21-SEP-2022) and NO ADVERSE EVENT (No adverse event) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057a22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Sep-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving a dose after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date/Vial was initially stored in the refrigerator on 19-AUG-2022 and vaccine was administered on 21-SEP-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving a dose after its beyond use date), PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date/Vial was initially stored in the refrigerator on 19-AUG-2022 and vaccine was administered on 21-SEP-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (receiving a dose after its beyond use date) and PRODUCT STORAGE ERROR (Dose administered after 30-day Use By Date/Vial was initially stored in the refrigerator on 19-AUG-2022 and vaccine was administered on 21-SEP-2022).    No concomitant medication details was reported. Individual vials or unbroken cartons- in the open box a sealed vial. Vial size was 5.5ml vial. On 19-AUG-2022 the vial was initially stored in the refrigerator. The vial did not undergone any temperature excursions. No treatment medication details was reported.